Andere Sprachen Aequus Pharmaceuticals Inc.

Aktien

A2ASE5

CA0076361033

AQS

Markt geschlossen - Toronto S.E. Andere Börsenplätze 21:49:19 01.05.2024			% 5 Tage	% 1. Jan.
0,01 ^CAD	-33,33 %		-33,33 %	-60,00 %

2023	Aequus Pharmaceuticals Inc. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 30. September 2023	CI
2023	Aequus Pharmaceuticals Inc. meldet Ergebnis für das zweite Quartal und die sechs Monate bis zum 30. Juni 2023	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Aequus Provides General Update and Fiscal 2023 Financial Results	30.04.
Aequus Reports Third Quarter 2023 Financial Highlights and General Update	30.11.
Aequus Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	29.11.
Aequus Announces New Financing	20.10.23
Aequus Announces New Financing and Provides Launch Update of Zimed Preservative Free (Bimatoprost 0.03%)	07.10.23
Aequus Reports Second Quarter 2023 Financial Highlights and General Update	30.08.23
Aequus Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	29.08.23
Aequus Says Zimed PF Now Available in Canada	24.08.23
Aequus Announces Zimed PF Now Available in Canada	24.08.23
Aequus Pharmaceuticals Inc. Announces Launch of Zimed PF in Canada	24.08.23
Aequus Pharmaceuticals Announces Zimed PF Website Launch	22.08.23
Aequus Announces Zimed PF Website Launch	22.08.23
Aequus Pharmaceutical Canada Announces a Pause in Sales of Evolve Intensive Eyedrops and Gel in Canada	21.08.23
Aequus Pharmaceuticals Pauses Sales Of Evolve Intensive Eyedrops, Gel in Canada	18.08.23
Aequus Pharmaceutical Canada Announces a Pause in Sales of Evolve Intensive Eyedrops and Gel in Canada	18.08.23
Aequus Pharmaceutical Canada Announces a Pause in Sales of Evolve Intensive Eyedrops and Gel in Canada	18.08.23
Aequus Pharmaceuticals Inc. Announces Pause in Sales of Evolve Intensive Eyedrop and Intensive Gel Products in Canada	18.08.23
Aequus Announces Financing to Support Launch of Zimed Preservative Free	07.07.23
Aequus Pharmaceuticals Announcds Financing to Support Launch of Zimed Preservative Free	07.07.23
Aequus Announces Financing to Support Launch of Zimed Preservative Free (Bimatoprost 0.03%)	07.07.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Aequus Pharmaceuticals Inc.

Aktien

A2ASE5

CA0076361033

AQS

Andere Sprachen

Filter